Nitin Jain

51PUBLICATIONS
211CO-AUTHORS
AutoimmunityGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|Jul 31, 2026
Immune hallmarks of recurrent immune checkpoint inhibitor-mediated inflammatory arthritis.

|Feb 27, 2026
The Care and Cure of the Leukemias in 2026.

Hagop Kantarjian, Helen T Chifotides, Fadi G Haddad

|Feb 26, 2026
Is CLL curable?

Nitin Jain, Alessandra Ferrajoli, Susan O'Brien

|Feb 12, 2026
Ibrutinib with Venetoclax in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: A Phase II Study.

Mahesh Swaminathan, Alessandra Ferrajoli, Philip A Thompson

|Dec 16, 2025
NAMPT inhibition uncovers therapeutic vulnerabilities to venetoclax and chemotherapy in acute myelogenous leukemia.

John R Sanchez, Chaomei Liu, Vishakha Pawar

|Dec 10, 2025
Clinical Outcomes of Adult Patients With Newly Diagnosed Mixed Phenotype Acute Leukemia.

Hannah Goulart, Farhad Ravandi, Nicholas J Short

Pageof 9

Frequent Collaborators

25 joint publications

Elias Jabbour

19 joint publications

Nicholas Short

19 joint publications

Hagop M Kantarjian

18 joint publications

Farhad Ravandi